21 May 2009
Microvescicular liver graft steatosis as a risk factor of ipf (initial poor function) in relation to suboptimal donor parameters
B Cieślak, Z Lewandowski, M Urban, B Ziarkiewicz-Wróblewska, M KrawczykAnn Transplant 2009; 14(1): 43-44 :: ID: 880357
Abstract
Aim: To find out the role of microvesicular graft steatosis in relation to donor's parameters.
Material/Methods: 269 consecutive orthotopic liver transplantations were
performed in the Department between 2004 and 2006. Donor parameters
(age, BMI, ICU stay, hypotension, cardiac arrest, vasoactive agents, sodium concentration, AST, ALT, GGT, bilirubin and APTT) and percentage of microvesicular graft steatosis data were collected into the study. Endpoint of the study was dysfunction of the liver graft (AST or ALT >2500 IU/L or prothrombin index < 50% during first 7 days after OLTx - orthotopic liver transplantation).
Results: The increase of microvesicular steatosis by 12% results in significant aggravation of the risk of IPF by 50%.
Conclusions: The microvesicular steatosis is a risk factor of hepatic early dysfunction after liver transplantation. Moreover, it seems that recipients are more exposed to IPF, if the microsteatosis occurs with other suboptimal donor's parameters. The results are shown as an odds ratio for IPF in the group of optimal and suboptimal donors.
Keywords: Liver Transplantation
In Press
Case report
Pulmonary Embolism Following Living Donor Hepatectomy: A Report of 4 Cases and Literature ReviewAnn Transplant In Press; DOI: 10.12659/AOT.946752
Most Viewed Current Articles
03 Jan 2023 : Original article 6,527
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
15 Aug 2023 : Review article 6,222
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
16 May 2023 : Original article 6,152
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
17 Jan 2023 : Original article 5,279
Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation i...DOI :10.12659/AOT.938595
Ann Transplant 2023; 28:e938595